NRC Health Gain (Loss) on Disposition of Assets
NRC Health (NRC) reported Gain (Loss) on Disposition of Assets of -$61.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-05
- NRC Health gain (loss) on disposition of assets for the quarter ending 2023-12-31 was $0.00.
- NRC Health gain (loss) on disposition of assets for the quarter ending 2022-12-31 was -$10.00K.
- NRC Health gain (loss) on disposition of assets for the quarter ending 2022-09-30 was -$1.00K.
- NRC Health gain (loss) on disposition of assets for the quarter ending 2021-12-31 was -$6.00K.
- NRC Health gain (loss) on disposition of assets for fiscal 2025 was -$61.00K.
- NRC Health gain (loss) on disposition of assets for fiscal 2024 was -$17.00K.
- NRC Health gain (loss) on disposition of assets for fiscal 2023 was $0.00.
- NRC Health gain (loss) on disposition of assets for fiscal 2022 was -$11.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$61.00K 10-K · filed 2026-03-05 | |||
| 2024-12-31 | -$17.00K 10-K · filed 2026-03-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |||
| 2022-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$11.00K derived: sum of 2 quarters · filed 2025-03-17 | -$11.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 | |||
| 2021-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$6.00K derived: sum of 2 quarters · filed 2024-02-27 | -$7.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$1.00K 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | -$1.00K 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$12.00K 10-K · filed 2023-03-03 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $46.00K derived: sum of 2 quarters · filed 2022-03-04 | $6.00K 10-K · filed 2022-03-04 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$40.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | -$40.00K 10-Q · filed 2020-08-07 | |||
| 2018-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$184.00K derived: sum of 2 quarters · filed 2021-03-05 | -$186.00K 10-K · filed 2021-03-05 | |
| 2018-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$212.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$2.00K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | -$26.00K 10-K · filed 2020-03-06 | |||
| 2016-12-31 | -$22.00K 10-K · filed 2019-03-08 | |||
| 2014-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$1.00K derived: sum of 2 quarters · filed 2017-03-03 | -$2.00K 10-K · filed 2017-03-03 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.00K 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$1.00K 10-Q · filed 2015-08-06 | |||
| 2013-12-31 | -$23.00K 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |